학술논문

Impact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2-positive primary breast cancer: Analysis from the ALTTO phase III randomized trial
Document Type
Article
Source
In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 1 May 2017, 35(13):1421-1429)
Subject
Language
English
ISSN
15277755
0732183X